Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CD133+ Cell Therapy for Refractory Coronary Heart Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Hospital y Clinica OCA, S.A. de C.V..
Recruitment status was  Recruiting
Information provided by:
Hospital y Clinica OCA, S.A. de C.V. Identifier:
First received: January 13, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)